Science · Innovation · Impact

Research & Impact

At Medicinal Technologies, every discovery is driven by purpose. From pioneering molecular equations to real-world therapeutic breakthroughs, our science is changing lives — one patient at a time.

6+Active R&D Areas
USAProud U.S. Manufacturer
100%Science-Backed Formulas

Real Stories

What Our Clients Are Saying

Hear directly from the people whose lives have been transformed by Medicinal Technologies' products.

★★★★★

I've mopped 2 loads of clothes, mopped my kitchen and bathroom floors. I loaded my shoulders and knees with the crack oil, and now I have my mobility back. Thank you for introducing me to this oil.

C
Carlotta
Verified User
★★★★★

I used the oil on my corns and now I can walk.

H
Helen
Verified User
★★★★★

I've been having pain in my arms for 2 years, and now it feels fine. It worked almost instantly.

L
Lisa
Verified User
★★★★★

I was in the bed with inflammation from accident wounds and used the oil. Within 48 hours I used it 3 times and I was back to my norm — no longer debilitated by the pain. It even got rid of my boil. It's a miracle in a bottle. It changed my life.

J
Janet
Verified User
★★★★★

I put the oil on my burn. The oil ceased the pain and you can't even tell that I had a burn. There's no scar. It's amazing.

J
Jean
Verified User
★★★★★

Because of a sports injury, I've had pain in my knees for years. RegenarX eliminated the pain. I'm in total awe of what it was able to do!

D
Donald
Verified User
★★★★★

There's nothing like it, it's part of my daily routine.

V
Victor
Verified User
★★★★★

My periods were irregular and heavy for months until I started MEnera. Now they come the same time every month and I use half the pads I did before.

M
Cathy
Verified User
★★★★★

I can't believe how regular my cycles are now. I used to have so much pain that I'd be debilitated for days — but not anymore. I truly love MEnera.

M
Mandie
Verified User
★★★★★

After trying for years to get pregnant, I tried MEnera and fell pregnant after a few months.

S
Sabrina
Verified User

Intellectual Property

Patents & Innovation Portfolio

Our intellectual property reflects years of rigorous scientific inquiry and breakthrough discoveries at the intersection of biomedicine and biotechnology.

Ref: MT-2024-001
The Tejeda Equation — Endometriosis Mechanism of Action
A revolutionary equation outlining the molecular mechanism by which Endometriosis develops, reshaping diagnostic and therapeutic approaches in gynecological biomedicine.
Ref: MT-2024-002
Small Cell Biologic RegenarX for Targeted Topical Therapy
Proprietary biologic RegenarX designed to address musculoskeletal inflammation, dermatological conditions, and pain management at the cellular level.
Ref: MT-2025-003
MEnera — Hormonal Cycle Regulation Biologic OTC Oral
Novel biopharmaceutical compound developed to regulate menstrual cycle irregularities and reduce associated pain and flow, supporting gynecological health outcomes.

* Additional patent information available upon request. Reference numbers shown for identification purposes.

Scientific Literature

Publications & Media Coverage

Our research has been recognized across leading scientific and media platforms, validating the significance of our innovations.

1
Research Publication
Developing Small Molecule Therapeutics for Inducing Abnormal Cell Apoptosis and Mitigating Chromosomal Aberrations
International Journal of Pharmaceutical Sciences
View Publication
2
Research Publication
Presigen IV: A Novel Biocellular Approach to Intraocular Pressure Regulation and Glaucoma Management
Asian Journal of Multidisciplinary Research & Review
View Publication
3
Research Publication
Decoding the Role of Genetic Biomarkers in Neurodegenerative Diseases - Dysregulations of RNA Binding Protein Aggregations and Molecular Pathophysiologies
Journal of Medicine and HealthCare
View Publication
4
Research Publication
Reversal Processes by Dynamic Therapies: Pathophysiology Biomarkers and Integrative Applications for Endometriosis Case Report
Asian Journal of Medicine
View Publication
6
Health • Biopharmaceuticals
Breaking Ground in Biopharmaceuticals: How Medicinal Technologies is Redefining Patient Access to OTC Biologics
MSN
View Coverage
7
Neurodegenerative Diseases • 2024
The Role of Genetic Biomarkers in Neurodegenerative Diseases: Dysregulations of RNA Binding Protein Aggregations and Molecular Pathophysiologies
Science World Report
View Coverage
8
Business • Integrative Biomedicine
Medicinal Technologies: Leading Innovations in Integrative Biomedicine
Outlook India
View Coverage
9
Ophthalmic Health • 2024
Pioneering Advancements in Ophthalmic Health: A Promising Prospect for Eye Care
Science Times
View Coverage
10
Womenpreneur • Reproductive Wellness
Transforming Reproductive Wellness: Pioneering Advances in Infertility Treatment by Dr. Sheryene Tejeda
The US Journal
View Coverage
11
Health
New Hope for Ophthalmic Health
Ritz Herald
View Coverage

Key Achievements

Research Highlights & Milestones

From foundational science to commercial-ready biologics, here are the milestones that define our journey.

The Tejeda Equation

Dr. Tejeda's groundbreaking equation describes the molecular mechanism of Endometriosis development, offering new diagnostic insight and reshaping treatment pathways across gynecological biomedicine.

Active Clinical Pipeline

We are advancing a pipeline of small cell biologics with potential over-the-counter impact — bridging laboratory breakthroughs with regulatory-ready therapeutic solutions.

Multi-Specialty R&D Focus

Our active research spans Oncology, Ophthalmology, and Gynecology — targeting complex disorders at their biological root with precision formulations developed in-house.

U.S.-Based Manufacturing

All research, development, and manufacturing operations are conducted entirely within the United States — ensuring quality, compliance, and accountability at every stage.

National Recognition

Medicinal Technologies has been recognized by FindATopDoc and featured across MSN, The Science Times, Science World Report, and the NY Weekly for scientific contributions.

Collaborative Science

We actively partner with academic institutions, clinical researchers, and industry collaborators to advance biopharmaceutical solutions that shape the future of personalized healthcare.

Notable Milestones

2022

Medicinal Technologies founded with a mission to advance science-backed biopharmaceutical therapies.

2023

Featured in The Science Times, NY Weekly, and additional national publications for research contributions.

2024

The Tejeda Equation published — a breakthrough in understanding Endometriosis at the molecular level. Recognized by FindATopDoc.

2025

Expanded R&D into Ophthalmology and Oncology; MEnera product line developed for gynecological support.

2026

Active clinical pipeline advancing toward regulatory review; continued U.S. manufacturing expansion.

Get Involved

Ready to Be Part of the Impact?

Whether you're a patient, researcher, or supporter — there's a place for you in our mission to advance health through science.

Title

Go to Top